Clinical Trial Update: Systemic Erythropoietin Injection in Patients Having Optic Atrophy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports the completion of Phase 1 and Phase 2 studies evaluating systemic erythropoietin injections in patients with optic atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Atrophy

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Alexandria University | Conditions: Optic Atrophy | Phase 1, Phase 2 | Status: COMPLETED